ScientiaCME Professional awareness of COPD best practice and guidelines

Details

Chronic obstructive pulmonary disease (COPD) is characterized by inflammation and obstruction of airflow in the lungs, resulting in difficulty breathing. It includes the conditions of emphysema and chronic bronchitis, both of which contribute to the deterioration of lung function. COPD is the fourth leading cause of death in the United States, with a prevalence of 14.2 million.

Topics Covered

Faculty introduction, disclosures

Introductory content:

Epidemiology: statistics and burden
Pathophysiology, clinical presentations, risk factors, diagnosis, and comorbidities
Impact of acute exacerbations on QoL, economic burden, and healthcare utilization
Treatment of COPD

· Guideline-supported pharmacotherapies and related clinical trial findings and real-world outcomes

· Bronchodilators

· Long-acting beta 2-agonists (LABA)

· LAMA

· ICS

· Dual therapy (LABA plus LAMA)

· Triple therapy (LABA plus LAMA plus ICS)

· Oral therapy

· Glucocorticoids

· Phosphodiesterase inhibitors

· Azithromycin

· Emerging and future therapies – targeting interleukins, additional combination products

· HCPs’ role in patient medication adherence

· Patient case(s)

Summary, conclusions, and best practice recap

Learning Objectives

By the end of the session the participant will be able to:

Recall risk factors, diagnostic criteria, clinical presentations, and treatment-related healthcare burdens associated with COPD.
Summarize current guideline-supported treatment approach along with the appropriate use of pharmacological and nonpharmacological interventions.
Identify the currently available and emerging pharmacotherapeutic treatments for management of COPD.
Formulate a treatment plan for a patient with COPD at different stages of severity.

Target Audience

HCPs including but not limited to: pulmonologists and primary care physicians; physician associates, nurse practitioners, pharmacists, and nurses who practice in the aforementioned areas of specialty; and any other healthcare professional with an interest in or who clinically encounter patients with COPD.

Additional credit info

ACCME Activity #202902469

ScientiaCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: ScientiaCME designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ toward the AMA Physician’s Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABIM MOC Credit Type: Medical Knowledge

Physicians: For maintenance of certification (MOC) points, you must enter your board certification ID # and birth date correctly. It is the learner’s responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC points for this activity. By providing this data, you acknowledge that it will be shared with ACCME and the applicable certifying board. Please note: Not all activities on this site provide MOC points. If this activity does not specify that it provides MOC points in this section, then it does NOT provide MOC points. This activity provides MOC points only for ABIM.

Pharmacists

ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE #0574-0000-25-002-H01-P. This is an Application (A)-type activity.

Pharmacists: You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner’s responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.

Nurses: The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. This activity is designated for up to 0.75 AMA PRA Category 1 Credit(s)™.

Physician Associates: The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit™ assigned by organizations accredited by the ACCME as satisfying Category 1 CME for National Commission on Certification of Physician Assistants (NCCPA) national certification maintenance. This activity is designated for up to 0.75 AMA PRA Category 1 Credit(s)™.

Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCB) states that continuing education providers accredited by the ACCME may provide acceptable, accredited Advanced Practice Provider content. This activity is designated for up to 0.75 AMA PRA Category 1 Credit(s)™.